Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘Florida’

November 7th, 2017

No moss here – Mayo Clinic research websites rolling along

By Elizabeth Zimmermann Young elizabethzimmermann

They say that a rolling stone gathers no moss, and at Mayo Clinic, our research and research education programs are always on the move. It’s hard to keep track of all the exciting work being done to help improve health for our patients, or the way they – and patients everywhere – experience health care. […]

View full entry

Tags: cell therapy, Christopher Evans, Department of Molecular Medicine, Dev Mukhopadhyay, DNA, Eva Galanis, Evanthia Galanis, Florida, gene therapy, Jim Maher, Louis J. Maher, Michael Krowka


October 10th, 2017

Researchers Link Alzheimer’s Gene to Type III Diabetes

By Kate Ledger k8ledger

Researchers have known for several years that being overweight and having Type II diabetes can increase the risk of developing Alzheimer’s disease. But they’re now beginning to talk about another form of diabetes—Type III diabetes—that’s also associated with the neurodegenerative disease. This newly defined diabetes occurs when the neurons in the brain become unable to […]

View full entry

Tags: Alzheimer's disease, APOE, diabetes, Florida, Guojun Bu, insulin deficiency, neurodegenerative disease, research


October 3rd, 2017

Alzheimer’s Researcher Receives MERIT Award

By Lynda de Widt ldewidt

Neuroscientist Guojun Bu, Ph.D., Mary Lowell Leary Professor of Medicine, on Mayo Clinic’s campus in Florida, has been selected to receive the prestigious Method to Extend Research in Time (MERIT) Award. Granted by the National Advisory Council on Aging, the award provides long-term research funding to outstanding principal investigators who have demonstrated success on projects […]

View full entry

Tags: Alzheimer's disease, amyloid, APOE, dr. guojun bu, Dr. Tushar Patel, Florida, Florida research, National Advisory Council on Aging, National Institute on Aging, NIA, NIH, research


September 20th, 2017

Expanding our fold – Mayo Clinic’s newest research related websites

By Elizabeth Zimmermann Young elizabethzimmermann

At Mayo Clinic, research is integral to everything we do. We would be unable to offer the highest possible levels of care and continually improve the practice of medicine without research, and the education programs and processes to make it a reality. We are pleased to introduce some of our newest programs – or in […]

View full entry

Tags: Alfredo Quinones-Hinojosa, bile duct cancer, brain cancer, brain tumor, Florida, gallbladder cancer, hepatitis, Lewis Roberts, liver cancer, nicotine dependence, research, Somali


May 18th, 2017

Meet the researcher – Betty Kim, M.D., Ph.D.: Harnessing Nanotechnology to Study Cancer

By Nicole Brudos Ferrara nicoleferrara

When you are a driven neurosurgeon but not a morning person, sometimes it’s about your socks. “I lose no time matching,” says Mayo Clinic’s Betty Kim, M.D., Ph.D. “They’re all the same color, so I can get an extra minute of sleep.” Yet, in her daily work, misplaced colors are critical. Dr. Kim is trained […]

View full entry

Tags: Betty Kim, cancer, Florida, Forefront, Jacksonville, Mayo Clinic Cancer Center, nanomedicine, neurosurgeon, oncology


May 9th, 2017

Increasing the Odds

By Lynda de Widt ldewidt

Increasing the Odds Mayo Clinic performs more transplants than any other organization in the country. That experience allows Mayo Clinic scientist-physicians to study stem cells and personalize drugs to fight organ rejection and increase the number of viable lungs. Immune-Building Stem Cell Research In the 1970s, when Cesar A. Keller, M.D., started his career in […]

View full entry

Tags: Alexander Parker, Center for Individualized Medicine, Center for Regenerative Medicine, Cesar Kellar, chronic organ rejection, Florida, Jacksonville, kidney transplant, lung restoration, lung transplant, Mark Stegall, regenerative medicine


February 9th, 2017

Paper, Paper, Paper, and all those little black dots!

By Elizabeth Zimmermann Young elizabethzimmermann

Why are you asking me this again? What does this have to do with my visit today? What does my doctor do with all these forms? These questions, and others, led researchers in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to consider the use of […]

View full entry

Tags: Center for the Science of Health Care Delivery, Dr. Ryan Uitti, EPROMS, Florida, Kern Center, patient reported outcomes, PROs


January 31st, 2017

Contrast Dye in Kidney Disease Patients: Reducing the Risk of an Important Diagnostic Tool

By Elizabeth Zimmermann Young elizabethzimmermann

Building the evidence base for best practice Medical research has resulted in many amazing diagnostic and treatment methods, tools and drugs. Today a physician can look inside her patient’s body through the aid of radiation and iodine-based dyes in the blood stream – both of which could be deadly in another time or place. This […]

View full entry

Tags: Clinical Imaging, contrast dye, Florida, kidney disease, nephropathy


January 24th, 2017

Introducing the Sepsis and Shock Response Team, and other care-improving research outcomes

By Elizabeth Zimmermann Young elizabethzimmermann

Sepsis is a potentially life-threatening complication of an infection. Typically, sepsis occurs in people who are already hospitalized, but is also diagnosed among patients who come to the emergency department. It is the most expensive condition treated in the U.S. In 2002, the Society of Critical Care Medicine and the European Society of Intensive Care […]

View full entry

Tags: American Journal of Medical Quality, Dr. Pablo Moreno, emergency department, Florida, Kern Center, Science of health care delivery, sepsis, Sepsis and Shock Response Team, Surviving Sepsis Campaign


December 29th, 2016

Drug combo stems tumor growth in lung cancer

By Nicole Brudos Ferrara nicoleferrara

Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]

View full entry

Tags: Alan Fields, auranofin, cancer stem cells, chemotherapy, Florida, Forefront, KRAS gene, lung cancer, PKCiota


Contact Us · Privacy Policy